By Associate Professor Tanya Lynn Applegate

Journal articles

Applegate TL; Karjalainen A; Bygrave FL, 1997, 'Rapid Ca2+ influx induced by the action of dibutylhydroquinone and glucagon in the perfused rat liver', Biochemical Journal, 323, pp. 463 - 467, http://dx.doi.org/10.1042/bj3230463

Conference Papers

Jin F; Patel P; McManus H; Bottiger D; Applegate T; Medland N; Wong A; Stoove M; Fairley C; Cornelisse V; Shaw M; Lewis DA; Thing C; Lee F; Aung HL; Grulich AE; Guy R, 2024, 'Defining the eligible population in gay and bisexual men (GBM) for gonorrhoea vaccines using national sentinel surveillance data in Australia', in SEXUAL HEALTH, CSIRO PUBLISHING, pp. 85 - 85

Verich A; Ramarao-Milne P; Comellas RR; Alharbi B; Trembizki E; Applegate TL; Bauer DC, 2024, 'Leveraging machine learning to accelerate Neisseria gonorrhoeae molecular target selection', in SEXUAL HEALTH, CSIRO PUBLISHING, pp. 77 - 77

Walsh KW; Martinello M; Churkin A; Lou S; Applegate T; Etzion O; Uprichard SL; Cotler SJ; Barash D; Matthews G; Dahari H, 2019, 'MODELING INDICATES 100% NEGATIVE PREDICTIVE VALUE OF ACHIEVING CURE IN SUBJECTS WITH RECENT HCV INFECTION TREATED FOR 6 WEEKS WITH SOFOSBUVIR AND RIBAVIRIN: THE DARE II STUDY', in HEPATOLOGY, WILEY, MA, Boston, pp. 969A - 970A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653503298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Howe A; Cento V; Knight N; Dietz J; Di Maio VC; De Salazar A; Popping S; Fourati S; Knops E; Kjellin M; Sayan M; Mor O; De Knegt RJ; Mitchell R; Tam EV; Pai R; Pereira OOC; Lennerstrand J; Wang GP; Wong A; Parczewski M; Applegate T; Ramji A; Perno CF; Kaiser R; Boucher CAB; Feld JJ; Pawlotsky J-M; Garcia F; Ceccherini-Silberstein F; Sarrazin C; Harrigan R, 2018, 'A Real World Resistance Profile of Virologic Failures Collected from an International Collaboration (SHARED)', in HEPATOLOGY, WILEY, CA, San Francisco, pp. 128A - 128A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, CA, San Francisco, 09 November 2018 - 13 November 2018

Artenie AA; Cunningham E; Conway B; Dalgard O; Powis J; Bruggmann P; Hellard M; Cooper C; Read P; Feld JJ; Hajarizadeh B; Amin J; Applegate TL; Dillon JF; Fraser C; Gane E; Litwin AH; Marks P; Matthews GV; Quiene S; Thurnheer MC; Weltman M; Dore G; Bruneau J; Grebely J, 2018, 'Drug and alcohol use patterns during and following treatment with sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use: Insights from trajectory analyses', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, pp. 31 - 32, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lamoury F; Bajis S; Hajarizadeh B; Marshall A; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing D; Kleman M; Cunningham P; Dore G; Applegate T; Grebely J, 2018, 'THU-093 Evaluation of the Xpert fingerstick HCV viral load assay', in Journal of Hepatology, Elsevier, pp. s167, http://dx.doi.org/10.1016/s0168-8278(18)30546-4

Lamoury F; Bajis S; Martinez D; Mowat Y; Jayasinghe I; Martinez M; Cunningham P; Catlett B; Jacka B; Marks P; Grebely J; Cloherty G; Dore G; Applegate T, 2018, 'THU-416 Evaluation of a hepatitis C virus core antigen assay in dried-blood spots: a cohort study', in Journal of Hepatology, Elsevier, pp. s317 - s318, http://dx.doi.org/10.1016/s0168-8278(18)30854-7

Grebely J; Lamoury F; Hajarizadeh B; Mowat Y; Marshall A; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore G; Applegate TL, 2017, 'SAT-206 Field evaluation of Xpert® HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples', in Journal of Hepatology, Elsevier, pp. s709, http://dx.doi.org/10.1016/s0168-8278(17)31900-1

Lamoury F; Hajarizadeh B; Martinello M; Soker A; Martinez D; Cunningham P; Cloherty GA; Marks P; Matthews G; Amin J; Grebely J; Dore G; Applegate TL, 2016, 'Hepatitis C virus core antigen: A simplified treatment monitoring tool among those with recent Hepatitis C virus infection, including for post-treatment relapse', in HEPATOLOGY, WILEY, MA, Boston, pp. 415A - 415A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hajarizadeh B; Grady B; Page K; Kim AY; Mcgovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J, 2014, 'Factors associated with hepatitis C virus RNA levels in early chronic infection: The InC3 study', in Journal of Viral Hepatitis, Blackwell Publishing Ltd, MA, Boston, pp. 708 - 717, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, http://dx.doi.org/10.1111/jvh.12384

Martinello M; Hellard M; Shaw D; Petoumenos K; Applegate T; Grebely J; Yeung B; Maire L; Iser D; Lloyd A; Thompson A; Sasadeusz J; Haber P; Dore GJ; Matthews GV, 2014, 'Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: The ATAHC II and DARE-C i studies', in Antiviral Therapy, SAGE Publications, MA, Boston, pp. 425 - 434, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, http://dx.doi.org/10.3851/IMP3035

Sheridan DA; Hajarizadeh B; Matthews G; Applegate TL; Douglas MW; Askew B; Neely D; Bassendine MF; Dore GJ; Lloyd AR; George J; Grebely J, 2014, 'Hepatitis C lipoviral particle levels are associated with spontaneous clearance of acute infection', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 929A - 929A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014

Jacka B; Poon A; Applegate TL; Krajden M; Olmstead A; Harrigan R; Marshall BD; DeBeck K; Milloy M-J; Lamoury F; Pybus O; Lima V; Magiorkinis G; Montoya V; Montaner J; Joy J; Dore GJ; Kerr T; Wood E; Grebely J, 2014, 'Hepatitis C virus network dynamics among people who inject drugs in Vancouver, Canada', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 907A - 908A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014

Olmstead A; Montoya V; Joy J; Luo I; Janjua NZ; Poon A; Jacka B; Lamoury F; Applegate TL; Grebely J; Harrigan R; Krajden M, 2014, 'Molecular sequencing and phylogenetics as enhanced surveillance tools for monitoring Hepatitis C virus transmission dynamics in British Columbia', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 283A - 283A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483801103&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hajarizadeh B; Grady BP; Page K; Kim AY; McGovern BH; Cox A; Rice TM; Sacks-Davis R; Bruneau J; Morris MD; Amin J; Schinkel J; Applegate TL; Maher L; Hellard M; Lloyd AR; Prins M; Dore GJ; Grebely J, 2014, 'Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study', in HEPATOLOGY, WILEY-BLACKWELL, MA, Boston, pp. 898A - 899A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, MA, Boston, 07 November 2014 - 11 November 2014

Jacka B; Applegate T; Poon AF; Harrigan R; Dore GJ; Olmstead A; DeBeck K; Milloy M-J; Lamoury F; Woods C; Brumme Z; Dobrer S; Lima VD; Montaner J; Joy J; Marshall BD; Kerr T; Wood E; Krajden M; Grebely J, 2014, 'P762 TEMPORAL CHANGES IN HEPATITIS C VIRUS GENOTYPE 3A DISTRIBUTION AMONG PEOPLE WHO INJECT DRUGS IN VANCOUVER, CANADA', in Journal of Hepatology, Elsevier, ENGLAND, London, pp. s324 - s325, presented at 49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, ENGLAND, London, 09 April 2014 - 13 April 2014, http://dx.doi.org/10.1016/s0168-8278(14)60923-5

Bradshaw D; Jacka B; Sacks-Davis R; Lamoury F; Applegate T; Dore G; Down I; Luciani F; Hellard M; Sasadeusz J; Danta M; Matthews G, 2014, 'A novel method comparing sexual networks with the HCV phylogeny in HIV-positive MSM with acute HCV infection identifies two potential intervention targets for permucosally transmitted HCV in Australia', in HIV MEDICINE, WILEY-BLACKWELL, pp. 136 - 136

Bradshaw D; Jacka B; Sacks-Davis R; Lamoury F; Applegate TL; Dore GJ; Down I; Luciani F; Hellard M; Sasadeusz J; Danta M; Matthews G, 2013, 'A novel method comparing sexual networks with the HCV phylogeny in HIV-positive men who have sex with men (MSM) with acute HCV infection identifies two potential intervention targets for permucosally-transmitted HCV', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 1307A - 1307A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, DC, Washington, 01 November 2013 - 05 November 2013

Bradshaw D; Lamoury F; Catlett B; Applegate TL; Mcallister J; Dore GJ; Matthews G; Danta M, 2013, 'Seminal HCV RNA level may mirror dynamics of plasma HCV RNA in HIV-positive men with acute HCV infection', in HEPATOLOGY, WILEY-BLACKWELL, DC, Washington, pp. 913A - 913A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, DC, Washington, 01 November 2013 - 05 November 2013

Jacka B; Lamoury F; Simmonds P; Dore GJ; Grebely J; Applegate T, 2013, '1159 SEQUENCING THE HEPATITIS C VIRUS: A SYSTEMATIC REVIEW', in Journal of Hepatology, Elsevier, pp. s471 - s472, http://dx.doi.org/10.1016/s0168-8278(13)61160-5

Grebely J; Feld JJ; Applegate T; Matthews G; Hellard M; Sherker A; Petoumenos K; Shaw I; Yeung B; Kaldor JM; Cherepanov V; Bruneau J; Lloyd A; Shoukry N; Dore G, 2012, '889 PLASMA IP10 LEVEL PREDICTS SPONTANEOUS CLEARANCE IN ACUTE HCV INFECTION', in Journal of Hepatology, Elsevier, SPAIN, Barcelona, pp. s346, presented at 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), SPAIN, Barcelona, 18 April 2012 - 22 April 2012, http://dx.doi.org/10.1016/s0168-8278(12)60901-5

Matthews G; Applegate TL; Tschochner M; Plauzolles A; Mallal SA; Grebely J; Hellard M; Lloyd AR; Kaldor JM; Dore GJ; Gaudieri S, 2011, 'ULTRA DEEP SEQUENCING ANALYSIS OF TREATMENT NAIVE INDIVIDUALS WITH RECENTLY ACQUIRED HEPATITIS C INFECTION DEMONSTRATES WIDESPREAD AMINO ACID VARIATION AT KEY PROTEASE AND POLYMERASE SITES OCCURRING AT LOW FREQUENCY', in HEPATOLOGY, WILEY-BLACKWELL, CA, San Francisco, pp. 1343A - 1344A, presented at 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), CA, San Francisco, 04 November 2011 - 08 November 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295578004555&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Applegate T; Gaudieri S; Pham S; White P; Grebely J; Hellard M; Suppiah V; George J; Lloyd A; Dore G; Matthews GV, 2011, 'Impact of host and viral characteristics on treatment outcome within hepatitis C transmission clusters in HIV-positive individuals with recently acquired HCV', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Los Cabos, MEXICO, pp. A87 - A87, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, Los Cabos, MEXICO, 07 June 2011 - 11 June 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375700092&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gaudieri S; Applegate T; Tschochner M; Plauzolles A; Pfafferott K; Lucas M; Diepolder H; Ulsenheimer A; Mallal S; Grebely J; Hellard M; Lloyd A; Kaldor J; Dore G; Matthews GV, 2011, 'Signature resistance mutations to directly acting antiviral agents occur at low prevalence in treatment-naive subjects with recently acquired hepatitis C infection', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Los Cabos, MEXICO, pp. A86 - A86, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, Los Cabos, MEXICO, 07 June 2011 - 11 June 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375700091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Applegate T; Gaudieri S; Pham S; White P; Grebely J; Hellard M; Suppiah V; George J; Lloyd A; Dore G; Matthews GV, 2011, 'Impact of host and viral characteristics on treatment outcome within hepatitis C transmission clusters in HIV-positive individuals with recently acquired HCV', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, pp. A87 - A87, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687677600071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Gaudieri S; Applegate T; Tschochner M; Plauzolles A; Pfafferott K; Lucas M; Diepolder H; Ulsenheimer A; Mallal S; Grebely J; Hellard M; Lloyd A; Kaldor J; Dore G; Matthews GV, 2011, 'Signature resistance mutations to directly acting antiviral agents occur at low prevalence in treatment-naive subjects with recently acquired hepatitis C infection', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, pp. A86 - A86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687677600070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Feld JJ; Grebely J; Applegate T; Matthews GV; Hellard M; Suppiah V; Sherker A; Petoumenos K; Shaw I; Yeung B; Rawlinson W; Booth D; Kaldor JM; Lloyd AR; Dore GJ, 2011, '1152 IP-10 IS ASSOCIATED WITH EARLY VIRAL KINETICS, BUT NOT SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION', in Journal of Hepatology, Elsevier, pp. s455, http://dx.doi.org/10.1016/s0168-8278(11)61154-9

Grebely J; Matthews GV; Hellard M; Suppiah V; Petoumenos K; Applegate T; Yeung B; Rawlinson W; Feld J; Lloyd AR; Booth D; Kaldor JM; George J; Dore GJ; Group OBOTAS, 2011, '1328 IL28B GENOTYPE HAS VARIABLE INFLUENCE ON EARLY VIRAL KINETICS, BUT NO INFLUENCE ON SUSTAINED VIROLOGICAL RESPONSE DURING TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION', in Journal of Hepatology, Elsevier, pp. s524, http://dx.doi.org/10.1016/s0168-8278(11)61330-5

Gaudieri S; Applegate T; Tshochner M; Plauzolles A; Pfafferott K; Lucas M; Diepolder H; Ulsenheimer A; Mallal S; Grebely J; Hellard M; Lloyd A; Kaldor J; Pore G; Matthews G; Group AS, 2011, '453 SIGNATURE RESISTANCE MUTATIONS TO DIRECTLY ACTING ANTIVIRAL AGENTS OCCUR AT LOW PREVALENCE IN TREATMENT NAIVE SUBJECTS WITH RECENTLY ACQUIRED HEPATITIS C INFECTION', in Journal of Hepatology, Elsevier, pp. s184 - s185, http://dx.doi.org/10.1016/s0168-8278(11)60455-8

Iland H; Bradstock K; Chong L; Springall F; Ayling J; Catalano A; Supple S; Todd A; Applegate T; Mokany E, 2003, 'Results of the APML3 trial of ATRA, intensive idarubicin, and triple maintenance combined with molecular monitoring in acute promyelocytic leukaemia (APL): A study by the Australasian leukaemia and lymphoma group (ALLG).', in BLOOD, AMER SOC HEMATOLOGY, CALIFORNIA, SAN DIEGO, pp. 141A - 141A, presented at 45th Annual Meeting of the American-Society-of-Hematology, CALIFORNIA, SAN DIEGO, 06 December 2003 - 09 December 2003, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186536700484&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Todd AV; Impey HL; Applegate TL; Haughton MA; Fuery CJ, 1999, 'Homogeneous amplification and detection of nucleic acid sequences using DzyNA (TM)-PCR.', in CLINICAL CHEMISTRY, AMER ASSOC CLINICAL CHEMISTRY, pp. 2049 - 2050, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083440300053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Apte MV; Norton ID; Haber PS; Applegate TL; Mccaughan GW; Korsten MA; Pirola RC; Wilson JS, 1997, 'Ethanol-induced increases in pancreatic enzyme content - a dietary artefact?', in Gastroenterology, W B Saunders Co, Philadelphia, PA, USA, pp. 112:4 A426, presented at Digestive Disease Week and the 98th Annual Meeting of the American Gastroenterological Association, Washington DC, USA, 11 May 1997 - 14 May 1997

Apte MV; Haber PS; Applegate TL; Norton ID; Korsten MA; Unknown ; Wilson JS, 1997, 'Generation of fatty acid ethyl esters by rat pancreatic acini: comparison of oxidative and non-oxidative ethanol metabolism', in Gastroenterology, W B Saunders Co, Philadelphia, PA, USA, pp. 112:4 A426, presented at Digestive Disease Week and the 98th Annual Meeting of the American Gastroenterological Association, Washington DC, USA, 11 May 1997 - 14 May 1997

Haber PS; Norton ID; Apte MV; Applegate TL; Korsten MA; Pirola RC; Wilson JS, 1997, 'Identification of stellate cells in the rat pancreas', in Gastroenterology, W B Saunders Co, Philadelphia, PA, USA, pp. 112:4 A446, presented at Digestive Disease Week and the 98th Annual Meeting of the American Gastroenterological Association, Washington DC, USA, 11 May 1997 - 14 May 1997

Apte M; Norton I; Haber P; Applegate T; McCaughan G; Korsten M; Pirola R; Wilson J, 1997, 'Ethanol-induced increases in pancreatic enzyme content - A dietary artefact?', in Gastroenterology, WB Saunders, pp. A426 - A426, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WV41901695&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Apte MV; Haber PS; Applegate TL; Norton ID; Korsten MA; Pirola RC; Wilson JS, 1997, 'Generation of fatty acid ethyl esters by rat pancreatic acini: Comparison of oxidative and non-oxidative ethanol metabolism.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A426 - A426, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WV41901697&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haber PS; Norton ID; Apte MV; Applegate TL; Korsten MA; Pirola RC; Wilson JS, 1997, 'Identification of stellate cells in the rat pancreas.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A446 - A446, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WV41901777&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Posters

Hengel B; Causer L; Matthews S; Applegate T; Anderson L; Patel P; Smith K; Andrewartha K; Guy R, 2022, 'Aboriginal and Torres Strait Islander COVID-19 point-of-care testing program: Test positivity over time 2020-2022', Sydney, presented at 2nd Australasian COVID-19 Conference, Sydney, 21 July 2022 - 22 July 2022, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/cf60e0bb3faf4c7dacc6b8b0dba1bbab

, 2015, 'P080: Characterizing hepatitis C virus transmission dynamics using molecular phylogenetic‐based methods', Vol. 22, pp. 60 - 60, http://dx.doi.org/10.1111/jvh.76_12425

Conference Presentations

Patel P; Applegate T; Andrewartha K; Causer L; Saha A; Kindinger A; Law H; Borgnolo B; Miller A; Martinez M; Crowley H; Williams A; Bodiyabadu K; Verich A; Khawar L; Alternetti N; Jayasinghe I; Matthews S; Guy R, 2023, '“It’s positive- now what?”: Developing systems to enable real-time public health action in a large decentralised remote and regional COVID-19 point of care testing program', presented at 1st Australasian Conference on Point of Care Testing for Infectious Diseases, 14 March 2023 - 15 March 2023, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/fa5b04cb2e4d4415806861f08a29540f

Hengel B; Causer L; Smith K; Applegate T; Patel P; Cooney L; Andrewartha K; Papa R; Hui B; Regan D; Matthews S; Guy R, 2023, 'Public health impact of molecular POC testing for COVID-19 in remote Aboriginal and Torres Strait Islander communities during the pandemic in Australia', presented at 1st Australasian conference on point of care testing for infectious diseases, Sheraton Grand Sydney Hyde Park, 14 March 2023 - 15 August 2023, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/fef20648acf947ad8041df1c63571040

Lamoury F; Soker A; Martinez D; Hajarizadeh B; Cunningham E; Bruggmann P; Foster G; Dalgard O; Conway B; Robaeys G; Swan T; Backmund M; Marks P; Grebely J; Dore GJ; Applegate TL, 2016, 'FRI-195 Hepatitis C Virus Core Antigen: A Simplified Treatment Monitoring Tool, including for Post-Treatment Relapse', http://dx.doi.org/10.1016/s0168-8278(16)01163-6

Conference Abstracts

Hajarizadeh B; George J; Levy M; Wong I; Howell J; Cabrera G; Tu E; Martinello M; Applegate T; Matthews G, 2024, 'Evaluation of a novel hepatitis B DNA test from fingerstick capillary blood at the point-of-care as a tool to enhance clinical management', in JOURNAL OF HEPATOLOGY, ELSEVIER, ITALY, Milan, Vol. 80, pp. S776 - S776, presented at European-Association-for-the-Study-of-the-Liver Congress (EASL), ITALY, Milan, 05 June 2024 - 08 June 2024

Matthews G; Bhagani S; Van der Valk M; Rockstroh JK; Kim AY; Thurnheer C; Feld JJ; Bruneau J; Gane EJ; Hellard M; Grebely J; Applegate T; Marks P; Martinello M; Petoumenos K; Dore G, 2019, 'SHORT COURSE DURATION SOFOSBUVIR/VELPATASVIR IS INFERIOR TO STANDARD DURATION THERAPY IN THE TREATMENT OF RECENTLY ACQUIRED HCV INFECTION: RESULTS FROM REACT STUDY', in HEPATOLOGY, WILEY, MA, Boston, Vol. 70, pp. 1487A - 1488A, presented at 70th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, MA, Boston, 08 November 2019 - 12 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000500824000056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthew G, 2019, 'Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E734 - E734, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019

Grebely J; Cunningham EB; Dalgard O; Hajarizadeh B; Conway B; Powis J; Bruneau J; Feld J; Read P; Cooper C; Amin J; Bruggmann P; Lacombe K; Stedman C; Hellard M; Marks P; Dunlop A; Moriggia A; Applegate T; Litwin A; Matthews G; Dore G, 2019, 'Reinfection following successful HCV DAA therapy among people with recent injecting drug use', in JOURNAL OF HEPATOLOGY, ELSEVIER, AUSTRIA, Vienna, Vol. 70, pp. E732 - E733, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), AUSTRIA, Vienna, 10 April 2019 - 14 April 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dalgard O; Grebely J; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2018, 'Sofosbuvir and Velpatasvir for Hepatitis C Virus Infection in People with Recent Injecting Drug Use (Simplify): An Open-Label, Single-Arm, Phase 4, Multicentre Trial', in HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, PACINI EDITORE, Vol. 20, pp. 14 - 14, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440974900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Martinello M; Bartlett S; Dore G; Bopage R; Finlayson R; Baker D; Bloch M; Doyle J; Shaw D; Hajkowicz K; Read P; Filep E; Lin L; Yee J; Applegate T; Hellard M; Matthews G, 2018, 'Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia', in Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia, Paris, France, presented at THE INTERNATIONAL LIVER CONGRESS 2018, Paris, France, 11 April 2018 - 15 April 2018

Martinello M; Cerrone M; Bhagani S; Gane E; Orkin C; Cooke G; Dore GJ; Petoumenos K; Applegate TL; Tu E; Marks P; Pagani N; Schoolmeesters A; Grebely J; Nelson M; Matthews GV, 2018, 'TARGET3D: high efficacy of 8 weeks paritaprevir/ritonavir/ombitasvir and dasabuvir among people with recent genotype 1 HCV infection', in HIV MEDICINE, WILEY, Vol. 19, pp. S151 - S152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000430174700440&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page